{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:29:35Z","timestamp":1766179775740},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":2375,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>\n\t\t\t\t\t\t<jats:italic>Aims<\/jats:italic>\u2007The objective of this study was to quantify the risk of serious blood and skin disorders associated with co\u2010trimoxazole.<\/jats:p><jats:p>\n\t\t\t\t\t\t<jats:italic>Methods<\/jats:italic>\u2007We conducted a population\u2010based cohort study of serious blood and skin disorders requiring hospitalization among otherwise healthy users of co\u2010trimoxazole at Group Health Cooperative and Puget Sound (GHC).<\/jats:p><jats:p>\n\t\t\t\t\t\t<jats:italic>Results<\/jats:italic>\u2007During the years 1987 to 1993 we found six cases of co\u2010trimoxazole\u2010associated blood disorders and three cases of co\u2010trimoxazole\u2010associated skin disorders yielding risks of 5.6\/100\u2003000 (95% CI 2.6\u201312.2) and 2.8\/100\u2003000 (95% CI 0.9\u20138.2) respectively. In all cases found there was prompt recovery after discontinuation of co\u2010trimoxazole. We found no cases of toxic epidermal necrolysis.<\/jats:p><jats:p>\n\t\t\t\t\t\t<jats:italic>Conclusions<\/jats:italic>\u2007We conclude that the risk of blood and skin disorders associated with the use of co\u2010trimoxazole leading to hospitalization is low.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1997.00584.x","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T16:49:57Z","timestamp":1066150197000},"page":"446-448","source":"Crossref","is-referenced-by-count":12,"title":["Hospitalization for serious blood and skin disorders followinguse of co\u2010trimoxazole"],"prefix":"10.1111","volume":"43","author":[{"given":"Marian Wald","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hershel","family":"Jick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,2]]},"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00584.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00584.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1997.00584.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:24:01Z","timestamp":1698409441000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1997.00584.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1046\/j.1365-2125.1997.00584.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1997.00584.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}